+143.3%
MRNA vs GTLB
+88.3%
+55.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | GTLB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -1.7% | -1.6% | -2.8% |
| 7D | -10.1% | -6.6% | -3.5% | -8.1% |
| 30D | +126.7% | +13.7% | +113.0% | +117.3% |
| 3M | +184.1% | +52.9% | +131.2% | +159.3% |
| 6M | +143.3% | +88.5% | +54.8% | +118.6% |
| All | +143.3% | +88.3% | +55.0% | +118.6% |
Cumulative growth
Daily Returns
Daily percentage return beside GTLB.
Daily Out/Under-Performance
Portfolio return minus GTLB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GTLB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded GTLB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling